Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Operating Income Loss of $4.55 million for the year ending 2025.
- CHAMPIONS ONCOLOGY, INC. showed an increase of +161.9% in Operating Income Loss from 2024 to 2025.
- This data is from CHAMPIONS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on July 23, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), CHAMPIONS ONCOLOGY, INC.'s Operating Income Loss has grown by 187.0%.
- Historical annual values: Fiscal year 2025: $4.55 million | Fiscal year 2024: -$7.36 million | Fiscal year 2023: -$5.26 million | Fiscal year 2022: $607.0 thousand | Fiscal year 2021: $366.0 thousand | Fiscal year 2020: -$1.92 million | Fiscal year 2019: $270.0 thousand | Fiscal year 2018: -$1.35 million | Fiscal year 2017: -$6.81 million | Fiscal year 2016: -$10.32 million | Fiscal year 2015: -$13.24 million | Fiscal year 2014: -$6.26 million | Fiscal year 2013: -$6.22 million | Fiscal year 2012: -$9.07 million | Fiscal year 2011: -$5.24 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: